GROUPE EUROMEDIS EO 2
Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more
Market Cap & Net Worth: GROUPE EUROMEDIS EO 2 (61R)
GROUPE EUROMEDIS EO 2 (F:61R) has a market capitalization of $13.37 Million (€13.03 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #31509 globally and #3491 in its home market, demonstrating a 0.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GROUPE EUROMEDIS EO 2's stock price €4.58 by its total outstanding shares 2844222 (2.84 Million).
GROUPE EUROMEDIS EO 2 Market Cap History: 2020 to 2026
GROUPE EUROMEDIS EO 2's market capitalization history from 2020 to 2026. Data shows change from $39.12 Million to $13.37 Million (-16.33% CAGR).
GROUPE EUROMEDIS EO 2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GROUPE EUROMEDIS EO 2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 61R by Market Capitalization
Companies near GROUPE EUROMEDIS EO 2 in the global market cap rankings as of March 18, 2026.
Key companies related to GROUPE EUROMEDIS EO 2 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
GROUPE EUROMEDIS EO 2 Historical Marketcap From 2020 to 2026
Between 2020 and today, GROUPE EUROMEDIS EO 2's market cap moved from $39.12 Million to $ 13.37 Million, with a yearly change of -16.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.37 Million | +19.90% |
| 2025 | €11.15 Million | -11.57% |
| 2024 | €12.61 Million | -15.29% |
| 2023 | €14.89 Million | +14.09% |
| 2022 | €13.05 Million | -55.74% |
| 2021 | €29.49 Million | -24.63% |
| 2020 | €39.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of GROUPE EUROMEDIS EO 2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.37 Million USD |
| MoneyControl | $13.37 Million USD |
| MarketWatch | $13.37 Million USD |
| marketcap.company | $13.37 Million USD |
| Reuters | $13.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.